Telix Pharmaceuticals H1 2023 Results Presentation

Loading viewer...

earnings

Format: PDF earnings

Telix Pharmaceuticals' H1 2023 results presentation covering the company's investigational radiopharmaceutical products and pipeline, including Illuccix® (Ga-68 gozetotide injection). The presentation outlines Telix's activities, financial results, and development progress as of August 2023.

Browse all earningss →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Telix Pharmaceuticals

View all →

Telix Pharmaceuticals 2019 Investor Introduction

investor_presentation

19 Pages

Telix Pharmaceuticals 2023 Annual General Meeting

annual_report

Similar earningss from other companies

Browse all →

Axiata Q1 2021 Earnings Results

earnings

30 Pages

Axiata Group Berhad

IGO Limited FY23 Results Presentation 2023

earnings